1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/64099
Full metadata record
DC FieldValueLanguage
dc.creatorDaniele Aparecida Silva Correiapt_BR
dc.creatorMariana Santos Felisbino Mendespt_BR
dc.creatorMayara Santos Mendespt_BR
dc.creatorGustavo Velasquez-melendezpt_BR
dc.date.accessioned2024-02-16T20:02:04Z-
dc.date.available2024-02-16T20:02:04Z-
dc.date.issued2017-
dc.citation.volume51pt_BR
dc.citation.issue1pt_BR
dc.citation.spage1pt_BR
dc.citation.epage10pt_BR
dc.identifier.doi10.1590/s1518-8787.2017051006113pt_BR
dc.identifier.issn15188787pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/64099-
dc.description.resumoOBJECTIVE: To estimate the prevalence of the contraindicated use of oral contraceptives and the associated factors in Brazilian women. METHODS: 20,454 women who answered the VIGITEL survey in 2008 also participated in this study, of which 3,985 reported using oral contraceptives. We defined the following conditions for the contraindicated use of contraceptives: hypertension; cardiovascular diseases such as heart attack, stroke/cerebrovascular accident; diabetes mellitus; being smoker and 35 years old or older. We estimated the prevalence and 95% confidence intervals of contraindicated use in users of oral contraceptives and the factors associated with contraindication by prevalence ratio and 95% confidence intervals. RESULTS: In the total population, 21% (95%CI 19.7–21.9) of women showed some contraindication to the use of oral contraceptives, of which 11.7% (95%CI 10.6–13.7) belonged to the group of users of oral contraceptives. The most frequent contraindication in users of oral contraceptives was hypertension (9.1%). The largest proportion of women with at least one contraindication was aged between 45 and 49 years (45.8%) and with education level between zero and eight years (23.8%). The prevalence of contraindication to oral contraceptives was higher in women less educated (zero to eight years of study) (PR = 2.46; 95%CI 1.57–3.86; p < 0.05) and with age between 35-44 years (PR = 4.00; 95%CI 2.34–6.83) and 45-49 years (PR = 5.59; 95%CI 2.90–10.75). CONCLUSIONS: Age greater than or equal to 35 and low education level were demographic and iniquity factors, respectively, in the contraindicated use of oral contraceptivespt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentENF - DEPARTAMENTO DE ENFERMAGEM MATERNO INFANTIL E SAÚDE PÚBLICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofRevista de Saúde Pública-
dc.rightsAcesso Abertopt_BR
dc.subjectContraceptives, Oral, Combinedpt_BR
dc.subjectPrescription Drug Misusept_BR
dc.subjectRisk Factors.pt_BR
dc.subjectWomen’s Healthpt_BR
dc.subjectReproductive Health Servicespt_BR
dc.subject.otherContraceptives, Oral, Combinedpt_BR
dc.subject.otherPrescription Drug Misusept_BR
dc.subject.otherRisk Factorspt_BR
dc.subject.otherWomen’s Healthpt_BR
dc.subject.otherReproductive Health Servicespt_BR
dc.titleFactors associated with the contraindicated use of oral contraceptives in brazilpt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://doi.org/10.1590/S1518-8787.2017051006113pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Factors associated with the contraindicated pdfa.pdf232.13 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.